Description
CJC-1295 + Ipamorelin Overview
The CJC-1295 + Ipamorelin blend combines two peptides studied for their effects on endocrine signaling pathways. CJC-1295 is a GHRH analog associated with sustained modulation of somatotroph axis activity and downstream signaling cascades.
Ipamorelin is a selective secretagogue-type peptide studied for its selective pituitary signaling activity without significant off-target pathway interference. Together, the two may provide complementary activity across endocrine and systemic pathways in experimental settings.
CJC-1295 + Ipamorelin Research Focus
Published laboratory and preclinical work on CJC-1295 + Ipamorelin has concentrated on the following areas:
- Somatotroph axis activity
- Selective pituitary signaling
- Complementary GHRH and secretagogue activity
- Downstream endocrine signaling cascades
Available Formats
CJC-1295 + Ipamorelin is available in 10mg vials. Each strength can be ordered as a single vial or as a pack of 10 vials; choose your options above before adding to the cart.
Handling and Storage
Store and handle CJC-1295 + Ipamorelin according to the product label and your laboratory’s standard operating procedures. For background on the factors that affect stability, such as temperature, moisture, light and repeated freeze-thaw cycles, read our guide to peptide storage and stability.
Reference
Teichman S.L. et al. (2006). Find this reference on PubMed.
Related Research Peptides
Browse the full Growth Hormone Axis Peptides range or search the shop.
For research use only. CJC-1295 + Ipamorelin is intended exclusively for legitimate laboratory research. It is not for human or veterinary consumption and is not a drug, food, supplement or cosmetic. Nothing on this page is medical advice. By purchasing, the buyer agrees to use this product in compliance with all applicable laws.
Reviews
There are no reviews yet.